HER2-Low Breast Cancer: Pathological and Clinical Landscape
2020 · Journal of Clinical Oncology · 776 citations
https://doi.org/10.1200/jco.19.02488
D
Dario Trapani
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
384
Papers
9.3K
Citations
43
h-index
132
i10-index
Dario Trapani is an academic researcher from Harvard University. The author has contributed to research in topics: Economic and Financial Impacts of Cancer & Cancer Genomics and Diagnostics & Advanced Breast Cancer Therapies. The author has an h-index of 43, co-authored 327 publications.
ORCID: 0000-0003-1672-9560Papers by this author
worksEarly breast cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
2023 · Annals of Oncology · 724 citations
https://doi.org/10.1016/j.annonc.2023.11.016
Practical classification of triple-negative breast cancer: intratumoral heterogeneity, mechanisms of drug resistance, and novel therapies
2020 · npj Breast Cancer · 305 citations
https://doi.org/10.1038/s41523-020-00197-2
Variant allele frequency: a decision-making tool in precision oncology?
2023 · Trends in cancer · 71 citations
https://doi.org/10.1016/j.trecan.2023.08.011
Tumor Infiltrating Lymphocytes across Breast Cancer Subtypes: Current Issues for Biomarker Assessment
2023 · Cancers · 66 citations
https://doi.org/10.3390/cancers15030767
Cancer medicines on the WHO Model List of Essential Medicines: processes, challenges, and a way forward
2022 · The Lancet Global Health · 61 citations
https://doi.org/10.1016/s2214-109x(22)00376-x
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat